Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia)
08:20am, Thursday, 24'th Oct 2024
Regardless of who wins the presidency, investors are better off focusing on top growth stocks.
Viking Therapeutics, Inc. (VKTX) Q3 2024 Earnings Call Transcript
08:00pm, Wednesday, 23'rd Oct 2024
Viking Therapeutics, Inc. (NASDAQ:VKTX ) Q3 2024 Earnings Conference Call October 23, 2024 4:30 PM ET Company Participants Stephanie Diaz – Manager-Investor Relations Brian Lian – President and Ch
Viking Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
04:05pm, Wednesday, 23'rd Oct 2024
Conference call scheduled for 4:30 p.m. ET today End-of-Phase 2 Meeting for Subcutaneous VK2735 for Obesity Planned for 4Q24 Phase 2 Study of Oral VK2735 in Obesity Expected to Begin 4Q24 Results of P
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
12:14pm, Tuesday, 22'nd Oct 2024
Viking Therapeutics Inc. VKTX is set to report its third-quarter earnings on Wednesday, after the market closes. The anticipation is palpable, especially as the stock has skyrocketed almost 240% year-
Viking Therapeutics Stock: Buy or Sell Before Q3 Earnings?
10:06am, Monday, 21'st Oct 2024
Devoid of marketed drugs, investors will likely focus on VKTX's pipeline updates when it reports third-quarter results.
Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider
06:50pm, Friday, 18'th Oct 2024
Viking Therapeutics, Inc. (VKTX) reachead $65.80 at the closing of the latest trading day, reflecting a +1.83% change compared to its last close.
Viking Stock Rises 29% in Three Months: Time to Buy, Hold or Sell?
09:50am, Friday, 18'th Oct 2024
VKTX continues to generate phenomenal returns, driven by encouraging updates from three promising pipeline programs.
Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future
08:30am, Thursday, 17'th Oct 2024
Viking recently announced the results of an early-stage clinical trial for VK0214.
Viking Therapeutics to Report Financial Results for Third Quarter 2024 on October 23, 2024
04:05pm, Wednesday, 16'th Oct 2024
Conference Call Scheduled for Wednesday, October 23 at 4:30 p.m. Eastern Time SAN DIEGO , Oct. 16, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharm
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?
10:39am, Monday, 14'th Oct 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Where Will Viking Therapeutics Be in 5 Years?
05:32am, Monday, 14'th Oct 2024
We could be witnessing the birth of a major player in the biotech industry.
Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics
12:11pm, Sunday, 13'th Oct 2024
It's hard to go wrong with either company, but one is more appealing.
The Ultimate Biotech Stock to Buy With $100 Right Now
03:15am, Saturday, 12'th Oct 2024
This company is operating in one of today's hottest markets.
Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market
06:55pm, Thursday, 10'th Oct 2024
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $62.45, representing a -0.3% change from its previous close.
Viking Therapeutics' stock boosted by positive data from trial of treatment for rare metabolic disorder X-ALD
07:41am, Wednesday, 09'th Oct 2024
Viking, which is also developing a weight-loss pill, has a buy rating from all 13 analysts offering coverage.
